MedStar Authors catalog › Details for: Obesity, Systemic Hypertension, and Pulmonary Hypertension: A Tale of Three Diseases. [Review]
Normal view MARC view ISBD view

Obesity, Systemic Hypertension, and Pulmonary Hypertension: A Tale of Three Diseases. [Review]

by Chopra, Rajus; Vedantam, Karthik S; Devraj, Mithun; Chowdary, Anil K; Navarengom, Keron.
Citation: Current Problems in Cardiology. :100599, 2020 May 18.Journal: Current problems in cardiology.Published: ; 2020ISSN: 0146-2806.Full author list: Wahab A; Dey AK; Bandyopadhyay D; Katikineni V; Chopra R; Vedantam KS; Devraj M; Chowdary AK; Navarengom K; Lavie CJ; Kolpakchi A; Jneid H.UI/PMID: 32560908.Subject(s): IN PROCESS -- NOT YET INDEXEDInstitution(s): MedStar Heart & Vascular InstituteDepartment(s): MedStar Georgetown University Hospital ResidentsActivity type: Journal Article.Medline article type(s): Journal Article | ReviewOnline resources: Click here to access online Digital Object Identifier: https://dx.doi.org/10.1016/j.cpcardiol.2020.100599 (Click here) Abbreviated citation: Curr Probl Cardiol. :100599, 2020 May 18.Abstract: Cardiovascular disease (CVD), especially ischemic heart disease and stroke, is the major cause of death worldwide, accounting for more than one-third of all deaths annually. Hypertension is the most prevalent and modifiable risk factor of CVD-related deaths. The same is true for obesity, which is currently being recognized as a major global epidemic. The prevalence of obesity in the United States has increased dramatically, from 13.4% in 1960 to 36.5% in 2014, with as much as 70.7% of the American adult population being overweight or obese (CDC). Epidemiological studies have shown that obesity predisposes to hypertension and CVD - with the relationship between markers of obesity and blood pressure being almost linear across different populations. In this review, we discuss systemic and pulmonary hypertension in the context of obesity. Copyright (c) 2020 Elsevier Inc. All rights reserved.

Powered by Koha